Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Maxwell Biosciences Marks Scientist Appreciation Day With Renewed Call to Recognize Scientists

By: Newsfile

Company holiday celebrates scientific impact and invites underrecognized researchers to connect

Austin, Texas--(Newsfile Corp. - August 18, 2025) - Maxwell Biosciences, a global health technology company pioneering a new category of immune-inspired small molecules called Claromers™, today celebrates Scientist Appreciation Day, an official company holiday that honors the essential contributions of scientists. The observance is a call to give scientists greater visibility and broader recognition of their work at a time when scientific research faces growing challenges in visibility, funding and public support.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/9658/262232_141c765f342278ba_001.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9658/262232_141c765f342278ba_001full.jpg

Scientist Appreciation Day is celebrated annually by Maxwell's team. This year, the company is sharing its message more broadly to recognize the impact of people behind global scientific progress and to invite scientists working on complex or overlooked problems to reach out and connect. Moving forward, Maxwell's observance of Scientist Appreciation Day will take place on the third Friday in August.

"At Maxwell, we believe scientists are heroes— almost like wizards working to improve the human experience while exploring the inner cosmos," said Scotch McClure, founder, CEO and chairman of Maxwell Biosciences. "Their work forms the backbone of human advancement, yet many receive little recognition. If you're an underfunded scientist with real vision— we see you. If you're a brilliant scientist with incredible discoveries awaiting the world's attention, reach out. We're inviting you."

In an era when researchers are expected to do more with less— often behind the scenes— Maxwell is making its appreciation public. The company invites researchers across fields such as biotechnology, medical sciences, materials science, immunology and AI-driven drug discovery to contribute to a shared vision to create health for the world, safely and affordably.

About Maxwell Biosciences
Maxwell Biosciences is an AI-driven global health technology company pioneering a new category of immune-inspired small molecules called Claromers. Designed to mimic the body's natural defenses, Claromers destroy pathogenic bacteria, viruses, fungi and biofilms— without harming healthy cells or the microbiome.

Originally developed for critical infectious diseases, Maxwell's technology is now entering commercial deployment across cosmetics, personal care, medical coatings and livestock health. Claromers require no refrigeration and are highly stable in even the harshest environments.

Backed by a decade of research, a robust patent portfolio and leadership with deep expertise in science, military, AI and global health, Maxwell has active partnerships with the US military and governments worldwide. FDA clinical trials are planned for 2026. Non-pharmaceutical commercialization begins in 2025, with pilot access with select partners already underway.

Maxwell's AI-first platform enables rapid innovation against the rising threat of resistant pathogens, offering scalable, shelf-stable and microbiome-resilient solutions for a healthier planet.

To learn more about Maxwell Biosciences, visit MaxwellBiosciences.com, or follow us on X and LinkedIn.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262232

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.